Anatomy and Human Sciences Department, King's College London, London Bridge, London, UK.
Int J Womens Health. 2013 Apr 17;5:177-86. doi: 10.2147/IJWH.S34442. Print 2013.
The analysis of fetal nucleic acids in maternal blood 13 years ago has led to the initiation of noninvasive methods for the early determination of fetal gender, rhesus D status, and a number of aneuploid disorders and hemoglobinopathies. Subsequently, a comparatively large quantity of fetal DNA and RNA has been demonstrated in amniotic fluid as well as small amounts in premature infant saliva. The DNA and RNA in amniotic fluid has permitted an analysis of core transcriptomes, whilst the DNA and RNA in saliva allows the early detection and treatment monitoring of fetal developmental problems. These aspects are discussed together with the methodology and limits of analysis for noninvasive prenatal diagnosis in predictive, preventive, and personalized medicine.
13 年前对母体血液中胎儿核酸的分析导致了非侵入性方法的出现,可用于早期确定胎儿性别、RhD 状态以及许多非整倍体疾病和血红蛋白病。随后,在羊水和早产儿唾液中也证明了相对大量的胎儿 DNA 和 RNA。羊水的 DNA 和 RNA 使得对核心转录组进行分析成为可能,而唾液的 DNA 和 RNA 则可以早期检测和监测胎儿发育问题。本文将讨论这些方面,以及在预测、预防和个性化医学中进行非侵入性产前诊断的分析方法和局限性。